XENIA PHARMA ApS: Financial statements 2025
CVR: 35529454
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
XENIA PHARMA ApS (CVR 35529454) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -28,827 and a net result of DKK -28,855 compared with DKK -18,952 the year before. Equity in the 2025 report amounted to DKK -46,501.
- Gross Profit
- DKK -28,827
- Profit/Loss
- DKK -28,855
- Equity
- DKK -46,501
- Total Assets
- DKK 41,269
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -29K | -29K | -47K | 0 |
| 2024 | - | -19K | -19K | -37K | 1 |
| 2023 | - | -19K | -16K | -35K | 1 |
| 2022 | - | -54K | -51K | -19K | - |
| 2021 | - | -27K | -28K | -19K | - |
Official annual report
How creditworthy is XENIA PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
XENIA PHARMA ApS has published its annual report for 2024. Gross profit came to DKK -18,943, and the net result was DKK -18,952.
About XENIA PHARMA ApS
XENIA PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company is registered under the industry Dyrlægeaktiviteter. The management consists of Dorte Xenia Gram. The company is owned by Dorte Xenia Gram. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,827 and a net result of DKK -28,855 compared with DKK -18,952 the year before. Equity in the 2025 report amounted to DKK -46,501.